HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gebitekin, C. Articles by Walker, D. R. Search for Related Content PubMed PubMed Citation Articles by Gebitekin, C. Articles by Walker, D. R.

European Journal of Cardio-Thoracic Surgery, Vol 8, 339-342, Copyright © 1994 by European Association for Cardio-thoracic Surgery

ARTICLES

Fate of patients with residual tumour at the bronchial resection margin

C Gebitekin, NK Gupta, CM Satur, G Olgac, PG Martin, NR Saunders and DR Walker
Department of Cardiothoracic Surgery, Killingbeck Hospital, Leeds, UK.

The presence of microscopic deposits of tumour cells at the bronchial resection margin (BRM) may adversely affect the prognosis of patients. Residual tumour cells were identified at the BRM in 40 (5.4%) of 735 patients who had been operated on for non-small cell lung carcinoma (NSCLC). The extent of disease was stage I in 7 (17.5%), stage II in 21 (52.5%), stage IIIa in 10 (25%) and stage IIIb in 2 (5%) patients. Malignant cells were found to have infiltrated the submucosal lymphatics in 5 (12.5%) cases and the peribronchial tissue in the remaining 35 (87.5%). Fifteen (37.5%) patients received adjuvant radiotherapy (RT). Recurrence of the disease was diagnosed in 29 (72.5%) patients after a median of 17 months (range 3-111). The recurrence was local in 17 (59%) and distant in 12 (41%). The 5-year overall actuarial survival rate was 21.6% and was not affected by RT (P = NS). Only patients with stage IIIa disease and a positive bronchial stump had a significantly reduced 5-year survival rate compared to those with a negative stump, 0% vs 17% (P < 0.001). Tumour cells at the resection margin did not affect the survival in this cohort except those with stage IIIa disease, and the addition of adjuvant RT did not significantly affect its recurrence in patients with NSCLC.

This article has been cited by other articles:

				J. Wind, E. J. Smit, S. Senan, and J.-P. Eerenberg Residual disease at the bronchial stump after curative resection for lung cancer Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 29 - 34. [Abstract] [Full Text] [PDF]

				S. Balasubramanian, J. Au, and J. Dunning Should lobectomy patients with microscopic involvement of the bronchial resection margin undergo re-operation to improve their long-term survival? Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 531 - 537. [Abstract] [Full Text] [PDF]

				R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ Type of resection and prognosis in lung cancer. Experience of a multicentre study Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 622 - 628. [Abstract] [Full Text] [PDF]

				A. Pasic, K. Grunberg, W. J. Mooi, M. A. Paul, P. E. Postmus, and T. G. Sutedja The Natural History of Carcinoma In Situ Involving Bronchial Resection Margins Chest, September 1, 2005; 128(3): 1736 - 1741. [Abstract] [Full Text] [PDF]

				M. Guo, M. G. House, C. Hooker, Y. Han, E. Heath, E. Gabrielson, S. C. Yang, S. B. Baylin, J. G. Herman, and M. V. Brock Promoter Hypermethylation of Resected Bronchial Margins: A Field Defect of Changes? Clin. Cancer Res., August 1, 2004; 10(15): 5131 - 5136. [Abstract] [Full Text] [PDF]

				C. Lequaglie, B. Conti, P.P. Brega Massone, and G. Giudice Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 229 - 232. [Abstract] [Full Text] [PDF]

				B. Passlick, I. Sitar, W. Sienel, O. Thetter, and A. Morresi-Hauf Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer Ann. Thorac. Surg., October 1, 2001; 72(4): 1160 - 1164. [Abstract] [Full Text] [PDF]

				M. Kara, S. Dizbay Sak, D. Orhan, and S. Kavukcu Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 350 - 355. [Abstract] [Full Text] [PDF]

				G. Massard, C. Doddoli, B. Gasser, X. Ducrocq, R. Kessler, C. Schumacher, G.-M. Jung, and J.-M. Wihlm Prognostic implications of a positive bronchial resection margin Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 557 - 565. [Abstract] [Full Text] [PDF]

				C. Ghiribelli, L. Voltolini, P. Paladini, L. Luzzi, M. Di Bisceglie, and G. Gotti Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 555 - 559. [Abstract] [Full Text] [PDF]

				R. J. Snijder, A. Brutel de la Riviere, H. J. J. Elbers, and J. M. M. van den Bosch Survival in Resected Stage I Lung Cancer With Residual Tumor at the Bronchial Resection Margin Ann. Thorac. Surg., January 1, 1998; 65(1): 212 - 216. [Abstract] [Full Text] [PDF]

				Y. Lacasse, H. C. Bucher, E. Wong, L. Griffith, S. Walter, R. J. Ginsberg, and G. H. Guyatt MD, "Incomplete Resection" in Non-Small Cell Lung Cancer: Need for a New Definition Ann. Thorac. Surg., January 1, 1998; 65(1): 220 - 226. [Abstract] [Full Text] [PDF]